Sanui H, Gery I
Department of Ophthalmology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Nippon Ganka Gakkai Zasshi. 1991 Feb;95(2):147-51.
We reported that R4 and R14 are uveitogenic synthetic peptides derived from bovine IRBP (interphotoreceptor retinoid-binding protein) in rats. R4 induced mild uveitis, while R14 induced severe uveitis with retinal detachment. In this experiment, a comparison of uveitogenicity, immune responses and capacity of uveitis transfer was made between R4 and R14. R14 was found to be approximately 1,000 times more uveitogenic than R4. R14 showed cross-reactivity with IRBP, original antigen, but R4 did not in lymphocytic proliferation assay and adoptive transfer experiment. Neither R4 nor R14 exhibited cross-reactivity with IRBP in antibody production in sera. Therefore, R14 is found to be an immunodominant site in the whole sequence of IRBP. It is conceivable that R14 plays an important role in uveitis induction and immune responses in rat immunized IRBP.
我们报道过,R4和R14是源自牛视网膜间质类视黄醇结合蛋白(IRBP)的致葡萄膜炎合成肽,可在大鼠中引发葡萄膜炎。R4诱发轻度葡萄膜炎,而R14诱发伴有视网膜脱离的重度葡萄膜炎。在本实验中,对R4和R14的致葡萄膜炎性、免疫反应及葡萄膜炎转移能力进行了比较。结果发现,R14的致葡萄膜炎性约为R4的1000倍。在淋巴细胞增殖试验和过继转移实验中,R14与原始抗原IRBP表现出交叉反应,但R4没有。在血清抗体产生方面,R4和R14均未与IRBP表现出交叉反应。因此,R14被发现是IRBP整个序列中的一个免疫显性位点。可以想象,R14在免疫IRBP的大鼠的葡萄膜炎诱导和免疫反应中起重要作用。